Management of inflammatory bowel disease in the elderly: do biologicals offer a better alternative?

@article{Ha2013ManagementOI,
  title={Management of inflammatory bowel disease in the elderly: do biologicals offer a better alternative?},
  author={Christina Y. Ha and Seymour Katz},
  journal={Drugs & aging},
  year={2013},
  volume={30 11},
  pages={871-6}
}
The management of inflammatory bowel disease (IBD) in elderly patients provides added complexity for healthcare providers who need to take into account the high likelihood of co-morbid disease, the need for polypharmacy and, in many instances, greater patient fragility. While biologics are often considered first-line corticosteroid-sparing strategies for moderate to severe disease, the additional variables unique to an elderly patient warrant consideration when discussing IBD therapeutics. As… CONTINUE READING